Parvovirus Reactivation in COVID-19

Division

Gulf Coast

Hospital

HCA Houston Healthcare Kingwood

Document Type

Case Report

Publication Date

9-7-2021

Keywords

sars-cov-2, covid-19, hypoproliferative anemia, immunosuppression, parvovirus b-19, parvovirus reactivation

Disciplines

Critical Care | Internal Medicine | Pulmonology | Respiratory Tract Diseases | Virus Diseases

Abstract

Anemia is a diagnostic challenge in patients with coronavirus disease 2019 (COVID-19). This is due to the broad differential of etiologies for anemia, which includes bleeding, bone marrow suppression secondary to sepsis, and hemolytic anemia. Here, we present a first-ever case of otherwise unexplained anemia in a patient receiving treatment for COVID-19 secondary to parvovirus B19 reactivation. While parvovirus infections often present as acute states of anemia, this patient developed a case of reactivation secondary to immunosuppression from COVID-19 treatment. This case indicates the importance of assessing for parvovirus infections in COVID-19 patients with otherwise unexplained anemia.

Publisher or Conference

Cureus

Link to Full Text

Share

COinS